A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells

Lin, Z., Bishop, K. S., Sutherland, H., Marlow, Gareth ORCID: https://orcid.org/0000-0002-7608-9086, Murray, P., Denny, W. A. and Ferguson, L. R. 2016. A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells. Molecular Biosystems 12 (3) , pp. 839-849. 10.1039/C5MB00554J

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Royal Society of Chemistry
ISSN:	1742-206X
Date of First Compliant Deposit:	16 December 2016
Date of Acceptance:	16 December 2015
Last Modified:	04 May 2023 21:26
URI:	https://orca.cardiff.ac.uk/id/eprint/96844

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item